• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. NV GXL LNR, LIPPED, 36MM ID, GROUP 3 CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. NV GXL LNR, LIPPED, 36MM ID, GROUP 3 CUPS; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED Back to Search Results
Model Number 132-36-53
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Codes Failure of Implant (1924); Inflammation (1932); Synovitis (2094); Implant Pain (4561)
Date of Event 07/07/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Pending evaluation.Concomitant device(s): 3733362 180-65-30 - alteon 6.5mm screw, 30mm, 4029458 180-65-15 - alteon 6.5mm screw, 15mm, 4305093 142-36-00 - cocr fem head 36mm +0 offset 12/14, 4392144 101-05-30 - 3.2mm drill bit30mm 1pk.
 
Event or Problem Description
It was reported that this female patient's left hip was revised 6 years post op due to polyethylene wear.X-ray revealed ¿evidence of significant polyethylene wear¿ and ¿evidence of osteolysis behind the socket.¿ defective gxl liner and femoral head were removed, and she was implanted with a new vitamin e 56/36 +10 degree novation xle acetabular liner and a 36 mm biolox delta femoral head.
 
Event or Problem Description
As reported via legal, that this female patient's left hip was revised 6 years post op due to polyethylene wear.X-ray revealed ¿evidence of significant polyethylene wear¿ and ¿evidence of osteolysis behind the socket.¿ the gxl liner and femoral head were removed, and she was implanted with a new vitamin e 56/36 +10 degree novation xle acetabular liner and a 36 mm biolox delta femoral head.No additional information.
 
Additional Manufacturer Narrative
Section h10: (h3) based on review of all available information, there is no evidence to suggest that the reported event is related to any design issues.The cause of the subsequent revision cannot be conclusively determined; however, it may have been the result of malalignment between the femoral and tibial components, third body wear, patient-related conditions, or any combination of these possibilities, which led to prosthesis wear.Section h11: the following sections have corrected information: (b5) describe event or problem: as reported via legal, that this female patient's left hip was revised 6 years post op due to polyethylene wear.X-ray revealed ¿evidence of significant polyethylene wear¿ and ¿evidence of osteolysis behind the socket.¿ the gxl liner and femoral head were removed, and she was implanted with a new vitamin e 56/36 +10 degree novation xle acetabular liner and a 36 mm biolox delta femoral head.No additional information.
 
Additional Manufacturer Narrative
H3: investigation results - based on the available information, the patient involved meets the following risk criteria for early prosthesis wear/osteolysis: implanted with a component having a shelf age of greater than 2 years.The most likely cause for the revision reported due to early prosthesis wear and osteolysis is a combination of the risk factors.However, this cannot be confirmed because the device was not available for evaluation and images and radiographs were not provided.
 
Event or Problem Description
As reported via legal documentation, a patient had their first left hip revision surgery on (b)(6) 2016.They underwent secondary revision surgery on (b)(6) 2022, approximately 6 years after their preceding revision.(b)(6) 2022 operation report state that there was significant synovitis, but the femoral and acetabular components were found to be stable and appropriately positioned.The surgeon noted that there was an uncontained defect in the central dome, which was debrided.The patient tolerated the procedure well, without complication and transferred to the recovery room in a stable post- operative condition.There is no other patient demographic or medical history available.There is no device return.There are no photos or other images of the device provided.No additional information is available.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay corrected information.The following sections were corrected: h6, h11.The reported event was unable to be confirmed due to limited information received from the customer.No device was returned for evaluation; further, photographs and/or radiograph images were not provided for review.A review of complaint history determined that no further action is required as no trends were identified.A definitive root cause was unable to be determined; however, may have resulted from prosthesis wear/osteolysis as specified in the hhe: implanted with a component having a shelf age of greater than 2 years.The most likely cause for the revision reported due to early prosthesis wear and osteolysis is a combination of the risk factors specified in the hhe.However, this cannot be confirmed because the device was not available for evaluation and images and radiographs were not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NV GXL LNR, LIPPED, 36MM ID, GROUP 3 CUPS
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66 ct
gainesville FL 32653
Manufacturer Contact
miguel sosa
3523771140
MDR Report Key15626386
Report Number1038671-2022-01319
Device Sequence Number6184225
Product Code JDI
UDI-Device Identifier10885862023421
UDI-Public10885862023421
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K070479
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer,Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 05/05/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/01/2019
Device Model Number132-36-53
Device Catalogue Number132-36-53
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/26/2022
Supplement Date Received by Manufacturer10/25/2022
12/22/2023
04/14/2026
Initial Report FDA Received Date10/18/2022
Supplement Report FDA Received Date11/11/2022
01/03/2024
05/05/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/07/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-1729-2022
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
Patient SexFemale
-
-